Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
about
In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems.Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
P2860
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@en
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@nl
type
label
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@en
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@nl
prefLabel
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@en
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
Therapeutic efficacy of BO-348 ...... sistant Staphylococcus aureus.
@en
P2093
Hashizume T
Nakagawa S
P2860
P304
P407
P577
1997-10-01T00:00:00Z